Satya Das, MD, MSCI

home / authors / satya-das-md-msci

Articles

Satya Das, MD, MSCI, on Research Presented at the 2021 ASCO Gastrointestinal Cancer Symposium

February 1st 2021

The expert in hematology/oncology discussed what research he is most looking forward to seeing the results of at the meeting.

Satya Das, MD, MSCI, on the Impact of PRRT in Patients With Well-Differentiated NETs

Satya Das, MD, MSCI

January 27th 2021

The expert in hematology/oncology discussed the implications of a study which evaluated the use of peptide receptor radionuclide therapy in patients with well-differentiated neuroendocrine tumors.

Satya Das, MD, MSCI, on the Use of PRRT in Patients With Well-Differentiated NETs

Satya Das, MD, MSCI

January 25th 2021

The expert in hematology/oncology discussed the results of a study which evaluated the use of peptide receptor radionuclide therapy in patients with well-differentiated neuroendocrine tumors.

Satya Das, MD, MSCI, on the Design of a Study of PRRT in Patients With Well-Differentiated NETs

Satya Das, MD, MSCI

January 15th 2021

The expert in hematology/oncology spoke about the study which evaluated the use of peptide receptor radionuclide therapy in patients with well-differentiated neuroendocrine tumors.